• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

设计、合成及生物评价 2-(苯氧甲基)-5-苯基-1,3,4-噁二唑衍生物作为抗乳腺癌药物。

Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.

机构信息

Drug Discovery Lab, Department of Chemistry, Annamalai University, Annamalai Nagar, 608002, Tamil Nadu, India.

Department of Pharmacology, PSG College of Pharmacy, Coimbatore, 641004, Tamil Nadu, India.

出版信息

Eur J Med Chem. 2019 Apr 15;168:1-10. doi: 10.1016/j.ejmech.2019.02.033. Epub 2019 Feb 15.

DOI:10.1016/j.ejmech.2019.02.033
PMID:30798049
Abstract

Structural based molecular docking approach revealed the findings of 2-(phenoxymethyl) -5-phenyl-1,3,4-oxadiazole derivatives. The compounds (7a-o) were synthesized and characterized well by using conventional methods. The compounds, 7b and 7m were reconfirmed through single crystal XRD analysis. The synthesized compounds (7a-o) were evaluated their antiproliferative activities against MCF-7 and MDA-MB-453. Furthermore, Lipinski's rule of five and pharmacokinetic properties were predicted for the test compounds. These results demonstrate that the compounds 7b and 7d exhibit more potent cytotoxicity and 7d exhibits dose-dependent activity and reduced cell viability. Further, the mechanism of action for the induced apoptosis was observed through morphological changes and western blotting analysis. These findings may furnish the lead for further development.

摘要

基于结构的分子对接方法揭示了 2-(苯氧甲基)-5-苯基-1,3,4-恶二唑衍生物的研究结果。这些化合物(7a-o)是通过常规方法合成并得到了很好的表征。化合物 7b 和 7m 通过单晶 XRD 分析得到了重新确认。对合成的化合物(7a-o)进行了 MCF-7 和 MDA-MB-453 的抗增殖活性评估。此外,对测试化合物进行了 Lipinski 五规则和药代动力学性质的预测。这些结果表明,化合物 7b 和 7d 表现出更强的细胞毒性,而 7d 表现出剂量依赖性活性和降低的细胞活力。此外,通过形态变化和 Western 印迹分析观察到诱导细胞凋亡的作用机制。这些发现可能为进一步的发展提供线索。

相似文献

1
Design, synthesis and biological evaluation of 2-(phenoxymethyl)-5-phenyl-1,3,4-oxadiazole derivatives as anti-breast cancer agents.设计、合成及生物评价 2-(苯氧甲基)-5-苯基-1,3,4-噁二唑衍生物作为抗乳腺癌药物。
Eur J Med Chem. 2019 Apr 15;168:1-10. doi: 10.1016/j.ejmech.2019.02.033. Epub 2019 Feb 15.
2
Design, Synthesis, and Biological Evaluation of 2-(2-Bromo-3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole Derivatives as Possible Anti-Breast Cancer Agents.设计、合成及生物评价 2-(2-溴-3-硝基苯基)-5-苯基-1,3,4-恶二唑衍生物作为潜在的抗乳腺癌药物。
Chem Biodivers. 2020 Feb;17(2):e1900659. doi: 10.1002/cbdv.201900659. Epub 2020 Jan 29.
3
Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme.设计、合成、建模研究和生物评价 1,3,4-噁二唑衍生物作为靶向胸苷磷酸化酶的有效抗癌剂。
Bioorg Chem. 2021 Jun;111:104873. doi: 10.1016/j.bioorg.2021.104873. Epub 2021 Mar 29.
4
Design and synthesis of novel HDAC8 inhibitory 2,5-disubstituted-1,3,4-oxadiazoles containing glycine and alanine hybrids with anti cancer activity.新型含甘氨酸和丙氨酸杂合物且具有抗癌活性的HDAC8抑制性2,5-二取代-1,3,4-恶二唑的设计与合成
Bioorg Med Chem. 2016 Nov 1;24(21):5611-5617. doi: 10.1016/j.bmc.2016.09.022. Epub 2016 Sep 12.
5
Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.设计、合成、体外和计算机评估一系列基于噁二唑的新型抗癌剂作为潜在的 Akt 和 FAK 抑制剂。
Eur J Med Chem. 2018 Jul 15;155:905-924. doi: 10.1016/j.ejmech.2018.06.049. Epub 2018 Jun 22.
6
Rationale Design, Synthesis, Cytotoxicity Evaluation, and Molecular Docking Studies of 1,3,4-oxadiazole Analogues.1,3,4-恶二唑类似物的原理设计、合成、细胞毒性评估及分子对接研究
Anticancer Agents Med Chem. 2018;18(1):121-138. doi: 10.2174/1871520617666170419124702.
7
Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.设计、合成、计算机模拟和生物评估新型基于吲哚的恶二唑衍生物对雌激素受体α的靶向作用。
Bioorg Chem. 2024 Jun;147:107341. doi: 10.1016/j.bioorg.2024.107341. Epub 2024 Apr 5.
8
Rational design-aided discovery of novel 1,2,4-oxadiazole derivatives as potential EGFR inhibitors.基于理性设计的新型 1,2,4-噁二唑衍生物的发现,作为潜在的表皮生长因子受体抑制剂。
Bioorg Chem. 2021 Sep;114:105124. doi: 10.1016/j.bioorg.2021.105124. Epub 2021 Jul 1.
9
New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.具有选择性 COX-2 和 EGFR 双重抑制活性的新型噁二唑类化合物:设计、合成、细胞毒性评价及计算机模拟研究。
Eur J Med Chem. 2019 Dec 1;183:111693. doi: 10.1016/j.ejmech.2019.111693. Epub 2019 Sep 10.
10
Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.新型 1,3,4-噁二唑同核核苷及其双头类似物的设计、合成、生物评价及分子对接研究作为抗肿瘤剂。
Bioorg Chem. 2021 Mar;108:104558. doi: 10.1016/j.bioorg.2020.104558. Epub 2020 Dec 15.

引用本文的文献

1
A two-decade overview of oxadiazole derivatives as promising anticancer agents.恶二唑衍生物作为有前景的抗癌药物的二十年综述。
RSC Adv. 2025 Sep 10;15(39):32778-32795. doi: 10.1039/d5ra03702f. eCollection 2025 Sep 5.
2
Unraveling Structural and Anticancer Properties of Pyridine-Oxadiazole Derivatives: Single-Crystal XRD, Hirshfeld Analysis, and Cytotoxicity against A549 Cells.吡啶-恶二唑衍生物的结构与抗癌特性解析:单晶X射线衍射、 Hirshfeld分析及对A549细胞的细胞毒性
ACS Omega. 2025 Jun 1;10(22):23549-23562. doi: 10.1021/acsomega.5c02152. eCollection 2025 Jun 10.
3
The combination of multi-approach studies to explore the potential therapeutic mechanisms of imidazole derivatives as an MCF-7 inhibitor in therapeutic strategies.
采用多种方法进行研究,以探索咪唑衍生物作为MCF - 7抑制剂在治疗策略中的潜在治疗机制。
Front Chem. 2023 Jun 27;11:1197665. doi: 10.3389/fchem.2023.1197665. eCollection 2023.
4
1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent.1,3,4-恶二唑:作为抗癌剂抑制胸苷磷酸化酶的新兴支架。
Curr Med Chem. 2024;31(38):6227-6250. doi: 10.2174/0929867331666230712113943.
5
Modular and Computational Access to Innocuous Multistep Metal-Free Synthesis of 1,3,4-Oxadiazoles as Enzyme Inhibitors.模块化与计算辅助的1,3,4-恶二唑类无害多步无金属合成作为酶抑制剂的方法
ACS Omega. 2023 Mar 26;8(13):11952-11965. doi: 10.1021/acsomega.2c07612. eCollection 2023 Apr 4.
6
Ligand-based designing of DPP-4 inhibitors via hybridization; synthesis, docking, and biological evaluation of pyridazine-acetohydrazides.基于配体的 DPP-4 抑制剂的杂交设计;哒嗪乙酰胺的合成、对接和生物评价。
Mol Divers. 2023 Dec;27(6):2729-2740. doi: 10.1007/s11030-022-10577-4. Epub 2022 Dec 19.
7
Oxadiazole Schiff Base as Fe Ion Chemosensor: "Turn-off" Fluorescent, Biological and Computational Studies.恶二唑席夫碱作为铁离子化学传感器:“关闭”荧光、生物学及计算研究
J Fluoresc. 2023 Mar;33(2):751-772. doi: 10.1007/s10895-022-03083-1. Epub 2022 Dec 14.
8
Synthesis and evaluation of anticancer activity of quillaic acid derivatives: A cell cycle arrest and apoptosis inducer through NF-B and MAPK pathways.奎来酸衍生物的合成及其抗癌活性评估:一种通过NF-κB和MAPK途径诱导细胞周期阻滞和凋亡的物质。
Front Chem. 2022 Sep 7;10:951713. doi: 10.3389/fchem.2022.951713. eCollection 2022.
9
Terminal Phenoxy Group as a Privileged Moiety of the Drug Scaffold-A Short Review of Most Recent Studies 2013-2022.端酚氧基作为药物支架的优势部分——对 2013 年至 2022 年最新研究的综述。
Int J Mol Sci. 2022 Aug 9;23(16):8874. doi: 10.3390/ijms23168874.
10
Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules.抗乳腺癌合成小分子药物研发的最新进展。
Molecules. 2021 Dec 15;26(24):7611. doi: 10.3390/molecules26247611.